Fish consumption and omega-3-fatty acids in prevention of diet-related noncommunicable diseases

Abstract

Diet-related noncommunicable diseases (DR-NCDs) which include obesity, hypertension, lipid disorders, type 2 diabetes mellitus, and cardiovascular (CV) disease are more common among people of South Asian descent because of genetic and other poorly understood factors. Indians are also one of the lowest consumers of fish and shellfish in the world despite being blessed with an extensive coastline. Consumption of fatty fish and fish oils supplementation has been demonstrated to improve blood pressure, lipid profiles, and CV outcomes. Data are still unclear if there is any impact on glucose intolerance with increased consumption of fatty fish or use of fish oils and omega-3-fatty acid (O3FA) supplements. The review focuses on the mechanisms of improvements with O3FAs on various aspects of DR-NCDs and reviews of current clinical data.

Cardiovascular disease - fatty fish - fish oils - noncommunicable diseases - omega-3-fatty acids

• References

• 1 Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93 (11) (Suppl. 01) S9-S30
• 2 Abegunde D, Stanciole A. World Health Organization Working Paper: An Estimation of the Economic Impact of Chronic Non-Communicable Diseases in Selected Countries. 2006; 001-021 Available from: http://www.who.int/chp/working_paper_growth%20model29may.pdf [Last accessed on 2016 Jun 20].
• 3 Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-1209
• 4 Ravikanth L, Kavikumar KS. Caught in the 'Net': Fish Consumption Patterns of Coastal Regions in India. 2015 Madras School of Economics. Available from: http://www.mse.ac.in/pub/Working%20Paper%20110.pdf [Last accessed on 2016 Jun 21].
• 5 Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757
• 6 American Heart Association Nutrition Committee. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S. et al. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 082-096
• 7 Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H. et al. Alpha-linolenic acid and risk of cardiovascular disease: A systematic review and meta-analysis. Am J Clin Nutr 2012; 96: 1262-1273
• 8 Welch AA, Shakya-Shrestha S, Lentjes MA, Wareham NJ, Khaw KT. Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the product-precursor ratio [corrected] of alpha-linolenic acid to long-chain n-3 polyunsaturated fatty acids: Results from the EPIC-Norfolk cohort. Am J Clin Nutr 2010; 92: 1040-1051
• 9 Harris WS. Fish oil supplementation: Evidence for health benefits. Cleve Clin J Med 2004; 71: 208-210
• 10 Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ. Long-chain conversion of [13C] linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 2005; 46: 269-280
• 11 Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011; 58: 2047-2067
• 12 Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: A systematic review. Br J Nutr 2012; 107 (Suppl. 02) S201-S213
• 13 Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-533
• 14 Mozaffarian D, Gottdiener JS, Siscovick DS. Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 2006; 97: 216-222
• 15 Fischer R, Dechend R, Qadri F, Markovic M, Feldt S, Herse F. et al. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension 2008; 51: 540-546
• 16 Harris WS, Rambjør GS, Windsor SL, Diederich D. N-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997; 65: 459-464
• 17 Rees D, Miles EA, Banerjee T, Wells SJ, Roynette CE, Wahle KW. et al. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am J Clin Nutr 2006; 83: 331-342
• 18 Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000; 192: 1197-1204
• 19 Serhan CN, Clish CB, Brannon J, Colgan SP, Gronert K, Chiang N. Anti-microinflammatory lipid signals generated from dietary n-3 fatty acids via cyclooxygenase-2 and transcellular processing: A novel mechanism for NSAID and n-3 PUFA therapeutic actions. J Physiol Pharmacol 2000; 51 (04) (Pt 1): 643-654
• 20 Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis 2008; 197: 012-024
• 21 Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides?. Curr Opin Lipidol 2006; 17: 387-393
• 22 Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005; 54: 1907-1913
• 23 Samuel S, Peskin B, Arondekar B, Alperin P, Johnson S, Blumenfeld I. et al. Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. Am J Cardiol 2011; 108: 691-697
• 24 Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, Meyer BJ. et al. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: Is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?. Nutr Metab Cardiovasc Dis 2007; 17: 572-580
• 25 Villegas R, Xiang YB, Elasy T, Li HL, Yang G, Cai H. et al. Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am J Clin Nutr 2011; 94: 543-551
• 26 Djoussé L, Gaziano JM, Buring JE, Lee IM. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 2011; 93: 143-150
• 27 van Woudenbergh GJ, van Ballegooijen AJ, Kuijsten A, Sijbrands EJ, van Rooij FJ, Geleijnse JM. et al. Eating fish and risk of type 2 diabetes: A population-based, prospective follow-up study. Diabetes Care 2009; 32: 2021-2026
• 28 Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A. Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: Systematic review and meta-analysis of prospective studies. Diabetes Care 2012; 35: 918-929
• 29 Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine n-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: A systematic review and meta-analysis. PLoS One 2012; 7: e44525
• 30 Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM. et al. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009; 90: 415-424
• 31 Calder PC. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res 2012; 56: 1073-1080
• 32 Shahzad K, Chokshi A, Schulze PC. Supplementation of glutamine and omega-3 polyunsaturated fatty acids as a novel therapeutic intervention targeting metabolic dysfunction and exercise intolerance in patients with heart failure. Curr Clin Pharmacol 2011; 6: 288-294
• 33 Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010; 303: 250-257
• 34 Lin PY, Chiu CC, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry 2012; 73: 1245-1254
• 35 Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: Metaregression analysis of randomized trials. J Hypertens 2002; 20: 1493-1499
• 36 Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM. et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; 2: 757-761
• 37 Campos H, Baylin A, Willett WC. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 2008; 118: 339-345
• 38 Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y. et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-1098
• 39 Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992; 85: 950-956
• 40 Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E. et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized, controlled trial. J Am Coll Cardiol 2005; 45: 1723-1728
• 41 Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R. et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1223-1230
• 42 Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T. et al. Lack of benefit of dietary advice to men with angina: Results of a controlled trial. Eur J Clin Nutr 2003; 57: 193-200
• 43 Kromhout D, Giltay EJ, Geleijnse JM. Alpha Omega Trial Group. N-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010; 363: 2015-2026
• 44 Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H. et al. Omega, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010; 122: 2152-2159
• 45 Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Baim DS. et al. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989; 2: 177-181
• 46 Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC. et al. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 2010; 3: 046-053
• 47 Dijkstra SC, Brouwer IA, van Rooij FJ, Hofman A, Witteman JC, Geleijnse JM. Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: The Rotterdam Study. Eur J Heart Fail 2009; 11: 922-928
• 48 Belin RJ, Greenland P, Martin L, Oberman A, Tinker L, Robinson J. et al. Fish intake and the risk of incident heart failure: The Women's Health Initiative. Circ Heart Fail 2011; 4: 404-413
• 49 Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008; 10: 503-509
• 50 Fares H, Lavie CJ, DiNicolantonio JJ, O'Keefe JH, Milani RV. Omega-3 fatty acids: A growing ocean of choices. Curr Atheroscler Rep 2014; 16: 389
• 51 Flock MR, Harris WS, Kris-Etherton PM. Long-chain omega-3 fatty acids: Time to establish a dietary reference intake. Nutr Rev 2013; 71: 692-707